Saccharomyces boulardii'. A Review of an Innovative Biotherapeutic Agent
Open Access
- 1 January 1993
- journal article
- review article
- Published by Taylor & Francis in Microbial Ecology in Health & Disease
- Vol. 6 (4) , 157-171
- https://doi.org/10.3109/08910609309141323
Abstract
Saccharomyces boulardii is a non-pathogenic yeast which has been used as both a preventive and therapeutic agent for the treatment of a variety of diarrhoeal diseases. The studies with animal models and evidence from human volunteers and patients indicate a profile which is effective in the therapy of diarrhoea and is remarkably safe for oral ingestion. The pharmacokinetic data demonstrate that 5. boulardü reaches a steady-state concentration quickly and maintains a high stable level as long as the yeast is taken daily. Once the agent is discontinued, S. boulardü is quickly eliminated from the colon. Clinical trials studying antibiotic-associated diarrhoea, nasogastric-tube alimentation diarrhoea, Clostridium difficile-disease, acute diarrhoea and chronic diarrhoea in HI V-infected patients are reviewed.Keywords
This publication has 43 references indexed in Scilit:
- Immunopharmacological effects of Saccharomyces boulardii in healthy human volunteersPublished by Elsevier ,2002
- Tube Feeding‐Related Diarrhea in Acutely III PatientsJournal of Parenteral and Enteral Nutrition, 1991
- Modulation of Clostridium difficile induced mortality as a function of the dose and the viability of the Saccharomyces boulardii used as a preventative agent in gnotobiotic miceCanadian Journal of Microbiology, 1991
- Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological studyJournal of General Microbiology, 1990
- Nosocomial Acquisition ofClostridium difficileInfectionNew England Journal of Medicine, 1989
- Bacterial Translocation in Patients with Colorectal CancerThe Journal of Infectious Diseases, 1988
- Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardiiCanadian Journal of Microbiology, 1986
- PROSPECTIVE RANDOMISED TRIAL OF METRONIDAZOLE VERSUS VANCOMYCIN FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHOEA AND COLITISThe Lancet, 1983
- Effect of -Lactam Antibiotics on the Resistance of the Digestive Tract of Mice to ColonizationThe Journal of Infectious Diseases, 1982
- DIARRHOEA: THE FAILURE OF COLONIC SALVAGEThe Lancet, 1982